rocketing ahead

Needless to say that if proven for human use, their antimicrobal drug will be a great asset.

They have to do more in vitro work perhaps followed by in vivo work in the lab.

Once everything is found satisfactory, I expect them to announce the start of PHASE I. This is not too expensive, but if successful, ought to increase the share price.

This in turn will come in handy should they want to make a placement to finance PHASE II.

If the clinical trials against the "Superbug" and the H. Pylori strain are successful, then the income from these sources could greatly outstrip that from animals.

The matter is that important I believe that CMQ wil move ahead when necessary and this is irrespective of any other business they are engaged in.

Gerry